Speakers

Leading industry voices.

Join senior regulatory, business development, R&D and market access experts from leading hybrid and 505(b)(2) companies across the US and Europe.

Ana Gavaldá, PhD.

ANNION

Founder of HYBRIDGE and Annion PM Managing Partner

Rosanne d'Alessio

ArendiBio Solutions

VP Business development

Drs. Hans Platteeuw

Galenicap

Chief Development Officer · Founder, Ziblets

James Burt

PLG/Galenicap

CEO at PLG and Board Advisor at Galenicap

Ana Catarina Pinto, PhD.

Bluepharma

Head of Portfolio Management

Ana Duarte

Farmaprojects, Polpharma Group

Senior Portfolio Manager

Will Bainbridge

Premier Consulting

Head of Global Commercial Strategy, Market Access & New Product Planning Consulting

Toni Santamaria

Adalvo

Chief Intellectual Property Officer

Irene Casalprim

Adalvo

Director of Intellectual Property

Nicolay Ferrari

ArendiBio Solutions

Owner & Senior Director of Research

Carlos Rodriguez

BCN Lifesciences

Founder

Víctor M. Díaz Pérez

Solitek Pharma

Co-founder and Operations Director

Alba Córdoba Insensé, PhD.

Nanomol Technologies

Business Unit Director - DELOS Technology

Paolo Raddani

Ziblets B.V.

Chief Executive Officer

Arnau Perdigó

Perdigó Medical

Chief Executive Officer

Dina Ferreira

Laboratorios Rubió

Chief Scientific Officer

Chrysa Daousani, PhD.

Pharminnova P.C.

Managing Director / Senior Consultant

Constance Montazel

Medicines for Europe

Value-Added Medicines Policy Manager